MAWCM
TEVA icon

Mine & Arao Wealth Creation & Management’s Teva Pharmaceuticals TEVA Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-600
Closed -$8.47K – 323
2024
Q1 		$8.47K Hold
600
– – ﹤0.01% 224
2023
Q4 		$6.26K Hold
600
– – ﹤0.01% 244
2023
Q3 		$6.12K Hold
600
– – ﹤0.01% 241
2023
Q2 		$4.52K Hold
600
– – ﹤0.01% 268
2023
Q1 		$5.31K Hold
600
– – ﹤0.01% 258
2022
Q4 		$5.47K Hold
600
– – ﹤0.01% 254
2022
Q3 		$5K Hold
600
– – ﹤0.01% 281
2022
Q2 		$5K Hold
600
– – ﹤0.01% 275
2022
Q1 		$6K Hold
600
– – ﹤0.01% 269
2021
Q4 		$5K Hold
600
– – ﹤0.01% 277
2021
Q3 		$6K Hold
600
– – ﹤0.01% 249
2021
Q2 		$6K Hold
600
– – ﹤0.01% 243
2021
Q1 		$7K Hold
600
– – ﹤0.01% 228
2020
Q4 		$6K Hold
600
– – ﹤0.01% 234
2020
Q3 		$5K Hold
600
– – ﹤0.01% 228
2020
Q2 		$7K Hold
600
– – 0.01% 197
2020
Q1 		$5K Hold
600
– – 0.01% 206
2019
Q4 		$6K Buy
+600
New +$5.36K 0.01% 210

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's TEVA Position: Q2 2024 in Review

Mine & Arao Wealth Creation & Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2024, closing a stake of 600 shares — an estimated $8.47K sold.

Mine & Arao Wealth Creation & Management first reported a position in TEVA in Q4 2019 and held it in 18 quarters. The position peaked at $8.47K in Q1 2024. 533 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • Mine & Arao Wealth Creation & Management reported no remaining Teva Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 600 Teva Pharmaceuticals shares in Q2 2024, an estimated $8.47K.
  • Mine & Arao Wealth Creation & Management first reported a position in Teva Pharmaceuticals in Q4 2019 and held it in 18 quarters.
  • Mine & Arao Wealth Creation & Management's Teva Pharmaceuticals position peaked at $8.47K in Q1 2024.
  • 533 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2024, filed 6 Aug 2024.